What is the recommended dosing for Midazolam (Versed)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Midazolam (Versed) Dosing Recommendations

Midazolam dosing varies significantly by indication and patient population, with procedural sedation requiring 0.05-0.1 mg/kg IV (maximum 5 mg initially) in adults under 60, while ICU sedation typically uses 2.5-5 mg/hr continuous infusion after a loading dose. 1, 2

Procedural Sedation/Anxiolysis

Adults Under 60 Years

  • Initial dose: 0.05-0.1 mg/kg IV given over 2-3 minutes 3, 2
  • Maximum single dose: 5 mg 3
  • Peak effect occurs at 3-5 minutes 3
  • Titrate by repeating doses every 3-5 minutes to avoid oversedation 3
  • Total doses >5 mg rarely necessary 2
  • Reduce dose by 30% if narcotic premedication or other CNS depressants used 2

Adults 60+ Years, Debilitated, or Chronically Ill

  • Start with no more than 1.5 mg over at least 2 minutes 2
  • Some patients respond to as little as 1 mg 2
  • Wait additional 2+ minutes between doses to fully evaluate sedative effect 2
  • Total doses >3.5 mg not usually necessary 2
  • Reduce dose by at least 50% if concomitant CNS depressants used 2

Pediatric Sedation

  • Ages 6 months-5 years: 0.05-0.1 mg/kg IV initially, up to 0.6 mg/kg total 4
  • Ages 6-12 years: 0.025-0.05 mg/kg IV initially, up to 0.4 mg/kg total 4
  • Children <6 years may require up to 1 mg/kg orally (maximum 20 mg) 3
  • Oral route: 0.5 mg/kg is effective in 76% of children for minor procedures 5

ICU Sedation (Continuous Infusion)

Note: Current evidence strongly favors minimizing benzodiazepine use in ICU due to increased delirium risk compared to propofol or dexmedetomidine 1

When Midazolam is Used

  • Loading dose: 0.01-0.05 mg/kg (approximately 0.5-4 mg) given slowly over several minutes 2
  • May repeat loading dose at 10-15 minute intervals until adequate sedation achieved 2
  • Maintenance infusion: 0.02-0.1 mg/kg/hr (1-7 mg/hr initially) 2
  • Alternative recommendation: 2.5-5 mg/hr (0.05-0.1 mg/kg/hr) titrated to light sedation 1
  • Adjust infusion rate by 25-50% based on sedation assessment every 1-2 hours 6, 2
  • If patient requires 2 bolus doses in one hour, double the infusion rate 3

Anesthesia Induction

Unpremedicated Adults <55 Years

  • 0.3-0.35 mg/kg IV over 20-30 seconds, allowing 2 minutes for effect 2
  • May use increments of 25% of initial dose if needed 2
  • Up to 0.6 mg/kg total may be used in resistant cases (prolongs recovery) 2

Unpremedicated Adults ≥55 Years

  • 0.3 mg/kg IV initially 2

Premedicated Adults <55 Years

  • 0.25 mg/kg IV over 20-30 seconds 2

Premedicated Adults ≥55 Years

  • 0.2 mg/kg IV 2

Patients with Severe Systemic Disease

  • 0.15-0.25 mg/kg IV (as little as 0.15 mg/kg may suffice) 2

Seizure Management

Acute Seizures (Pediatric)

  • IM: 0.2 mg/kg (maximum 6 mg per dose), may repeat every 10-15 minutes 3

Status Epilepticus (Adult)

  • IM: 15 mg as initial dose 7
  • IV loading dose: 0.15-0.2 mg/kg (7.5-10 mg), followed by continuous infusion starting at 3 mg/hr (0.06 mg/kg/hr) 1
  • For refractory status epilepticus: increase infusion by 1 mg/kg/min increments every 15 minutes (maximum 5 mg/kg/min) until seizures stop 3

Special Population Adjustments

Hepatic or Renal Impairment

  • Reduce dose by at least 20% due to decreased clearance 1, 6

Concurrent Opioid Use

  • Reduce midazolam dose by at least 20% due to synergistic respiratory depression 1
  • When combined with fentanyl, hypoxemia occurs in 92% and apnea in 50% of patients 8

H2-Receptor Antagonist Use

  • Reduce dose by 30% due to increased bioavailability 1

Critical Safety Considerations

Respiratory Monitoring

  • Respiratory depression can occur up to 30 minutes after administration 1
  • Monitor oxygen saturation continuously 6, 9
  • Be prepared to provide respiratory support regardless of route 3, 6
  • Have flumazenil available for reversal of life-threatening respiratory depression 3, 1, 6

High-Risk Combinations

  • Combining midazolam with opioids dramatically increases respiratory depression risk 1, 8
  • 78% of midazolam-associated deaths were respiratory in nature; 57% involved concurrent opioid use 8
  • When combining with olanzapine, use extreme caution due to risk of oversedation and respiratory depression 3

Common Pitfalls

  • Paradoxical agitation may occur, especially in younger children (6% incidence) 3, 5
  • Elderly patients have slower peak effect—wait longer between doses 2
  • Titrate slowly in patients with COPD or when co-administered with antipsychotics 3
  • Flumazenil reverses both respiratory depression AND anticonvulsant effects, potentially precipitating seizures 3, 6

Alternative Routes

Subcutaneous/Intramuscular

  • Delirium management: 2.5 mg SC/IV every 1 hour PRN (maximum 5 mg) 3
  • Use lower doses (0.5-1 mg) in elderly, frail, or COPD patients, or when co-administered with antipsychotics 3

Oral

  • Pediatric procedural sedation: 0.5 mg/kg (onset 15 minutes, effective in 76%) 5
  • Produces amnesia in 66% of children 5

References

Guideline

Midazolam Dosing and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Oral midazolam for conscious sedation of children during minor procedures.

Journal of accident & emergency medicine, 1998

Guideline

Midazolam Dosing Considerations After Rapid Sequence Intubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Midazolam use in the emergency department.

The American journal of emergency medicine, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.